7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:25256810 | ||||
pmid:25255977 | ||||
pmid:25243582 | ||||
pmid:27339288 | ||||
pmid:27334353 | ||||
pmid:27188231 | ||||
pmid:27119523 | ||||
pmid:25017214 | ||||
pmid:26946239 | ||||
pmid:26945169 | ||||
pmid:24767560 | ||||
pmid:24758546 | ||||
pmid:26691295 | ||||
pmid:26672708 | ||||
pmid:24356952 | ||||
pmid:24356935 | ||||
pmid:26419509 | ||||
pmid:26418168 | ||||
pmid:23500899 | ||||
pmid:23279451 | ||||
pmid:26149648 | ||||
pmid:26143141 | ||||
pmid:25926255 | ||||
pmid:25926154 | ||||
pmid:28385082 | ||||
pmid:28373003 | ||||
pmid:25724681 | ||||
pmid:25708645 | ||||
pmid:27983911 | ||||
pmid:27976811 | ||||
pmid:25475449 | ||||
pmid:25464125 | ||||
pmid:28488158 | ||||
pmid:28473060 | ||||
Wang Y et al. | Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. | Phytomedicine | pmid:24854571 | |
pmid:12354528 | ||||
pmid: | ||||
Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
Hofbauer LC and Heufelder AE | Osteoprotegerin: a novel local player in bone metabolism. | 1997 | Eur. J. Endocrinol. | pmid:9368500 |
Simonet WS et al. | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. | 1997 | Cell | pmid:9108485 |
Kwon BS et al. | TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. | 1998 | FASEB J. | pmid:9657524 |
Hofbauer LC et al. | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9784422 |
Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
Takai H et al. | Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. | 1998 | J. Biol. Chem. | pmid:9765225 |
Lacey DL et al. | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. | 1998 | Cell | pmid:9568710 |
Tomoyasu A et al. | Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9571159 |
Bucay N et al. | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. | 1998 | Genes Dev. | pmid:9573043 |
Yamaguchi K et al. | Characterization of structural domains of human osteoclastogenesis inhibitory factor. | 1998 | J. Biol. Chem. | pmid:9478964 |
Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
Schinke T et al. | Molecular determinants of arterial calcification. | 1998 | Ann. Med. | pmid:9920355 |